Altium Capital Management LP Coherus Bio Sciences, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$12.95 - $15.41 $1.77 Million - $2.11 Million	-136,623 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$14.42 - $21.39 $1.16 Million - $1.72 Million	-80,302 Reduced 37.02%	136,623 $2 Million
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $3.59 Million - $4.11 Million	216,925 New	216,925 $3.77 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.